by Jordana Choucair | Mar 22, 2022 | Opioid/Substance Use Disorders
A new RAND Corp. study found that less than a third of patients who were given drugs in emergency departments to treat opioid addiction follow up and continue their treatments. The study examined 92 percent of prescriptions filled at U.S. retail pharmacies before and...
by Jordana Choucair | Mar 22, 2022 | Opioid/Substance Use Disorders
According to a new study published in JAMA, alcohol-related deaths reached record levels during the first year of the COVID-19 pandemic. The number of deaths involving alcohol increased from 78, 927 in 2019 to 99,017 in 2020. Young adults ages 25 to 44 experienced the...
by Jordana Choucair | Mar 21, 2022 | D.C. News
Confirmation hearings for the Supreme Court nominee Judge Ketanji Brown Jackson will kick off later today. Jackson is a former federal public defender who has sat on lower U.S. courts for nearly a decade. Early in her career, she also served as a law clerk to retiring...
by Jordana Choucair | Mar 21, 2022 | Life Sciences
A new study published in JAMA Network Open found that the Johnson & Johnson (J&J) COVID-19 vaccine remains durable and effective. According to the research, the J&J shot was 76 percent effective in preventing COVID-19 infections and 81 percent effective in...
by Jordana Choucair | Mar 21, 2022 | Life Sciences
AstraZeneca announced its antibody-based cocktail to prevent and treat COVID-19 retained neutralizing activity against Omicron COVID-19 variants, including the BA.2 sub-variant. Britain’s drug regulator approved the therapy, called Evusheld, last week for preventing...
Recent Comments